GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Institut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain. aceriell@clinic.ub.es.|Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Hospital Clinic, Barcelona, Spain. aceriell@clinic.ub.es.
Antonio
A
Ceriello
Institut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Lucia
L
La Sala
Institut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Valeria
V
De Nigris
Institut d' Investigación Biomédiques August Pi i Sunyer (IDIBAPS), C/Rosselló, 149-153, 08036, Barcelona, Spain.
Gemma
G
Pujadas
Experimental Models in Clinical Pathology, INRCA-IRCCS National Institute, Ancona, Italy.
Roberto
R
Testa
Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, MI, Italy.|University of Milan, Milan, Italy.
Annachiara
A
Uccellatore
Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, MI, Italy.
Stefano
S
Genovese
D000328:Adult; D015703:Antigens, CD / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D000071063:Endoglin; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000378:metabolism*; D007003:Hypoglycemia / Q000378:metabolism*; D008297:Male; D053511:Matrix Metalloproteinase 14 / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism*; D055815:Young Adult
D015703:Antigens, CD; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface; D052216:Glucagon-Like Peptide 1; D053511:Matrix Metalloproteinase 14